Related Articles
CD55 and CD59 expression protects HER2‑overexpressing breast cancer cells from trastuzumab‑induced complement‑dependent cytotoxicity
FEN1 knockdown improves trastuzumab sensitivity in human epidermal growth factor 2‑positive breast cancer cells
Rapamycin enhances the sensitivity of ER‑positive breast cancer cells to tamoxifen by upregulating p73 expression
Anthocyanins potentiate the activity of trastuzumab in human epidermal growth factor receptor 2‑positive breast cancer cells in vitro and in vivo
Long‑responders to anti‑HER2 therapies: A case report and review of the literature